original articlesgastrointestinal tumorsBevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)
gastrointestinal tumors
Under an Elsevier user license
open archive
metastatic colorectal cancer
bevacizumab
maintenance therapy
Cited by (0)
- †
Present address: Department of Oncology, St Claraspital, Basel, Switzerland.
Copyright © 2015 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.